Is this bike race sponsorship dopey?

Sometimes event sponsorships can send the wrong message, as Budweiser found out with its ill-fated "Bud Pong" games. Biotech firm Amgen kicked up a fuss in the cycling world this week by announcing it signed on as the title sponsor the Tour of California, a 700-mile bike race. The problem is Amgen is the maker of synthetic erythropoietin, or EPO, a very useful drug used by anemia-plagued chemotherapy patients to increase their red blood cell production for more energy.